Salome Mekhuzla/LinkedIn
Oct 17, 2025, 08:37
Salome Mekhuzla Invites You to Join WHO Essential Medicines List 2025 Updates Webinar on Hemophilia and VWD
Salome Mekhuzla, Director of Global Development at the World Federation of Hemophilia, reposted from WFH on LinkedIn:
”Join us tomorrow to learn about the WHO Essential Medicines List 2025 updates in relation to treatment of hemophilia and vWD and what impact these critical changes could have on treatment access.”
Quoting WFH‘s post:
”Don’t miss tomorrow’s webinar WFH informational webinar on the recent milestone revisions to the WHO Essential Medicines List (EMLs)!
Hear about the advocacy efforts led by the WFH and partners, the key updates to the EMLs, and what these changes mean in practice for our community.
Register now.”
Stay updated with Hemostasis Today.
-
Sep 30, 2026, 15:58Bernhard Merget: New Frontiers in Thrombosis and Stroke Research
-
Sep 30, 2026, 15:39Ifeanyichukwu Ifechidere: The Molecular Orchestra of Primary Hemostasis
-
Sep 30, 2026, 15:28Reassessing the Benefit–Risk Balance of Extended Anticoagulation in Cancer Patients – ESC Working Group on Cardiovascular Pharmacotherapy
-
Sep 30, 2026, 15:07Chiranjeev Sharma: Targeting Factor XIa with the Synthetic Inhibitor SB-01
-
Sep 30, 2026, 14:41Bruna Gigante: Balancing Thrombosis and Bleeding in Cardiovascular Care
-
Sep 30, 2026, 14:13Ashok Choudhury: Portal Vein Thrombosis and Outcomes in Cirrhosis
-
Sep 30, 2026, 13:57Leslye Conde Bazán: When Conventional Imaging Is Not Enough – The Role of IVUS
-
Sep 30, 2026, 13:41Huda Salah Eldin: The Challenge of Balancing Antithrombotic Therapy After PCI
-
Sep 30, 2026, 13:29Abdus Salam: What Can CT Venography Reveal About the Veins?